Cargando…
Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders
Up to 50% of long-term HIV infected patients, including those with systemically well-controlled infection, commonly experience memory problems and slowness, difficulties in concentration, planning, and multitasking. Deposition of Aβ plaques is also a common pathological feature of HIV infection. How...
Autores principales: | Giunta, Brian, Ehrhart, Jared, Obregon, Demian F, Lam, Lucy, Le, Lisa, Jin, JingJi, Fernandez, Francisco, Tan, Jun, Shytle, R Douglas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128056/ https://www.ncbi.nlm.nih.gov/pubmed/21649911 http://dx.doi.org/10.1186/1756-6606-4-23 |
Ejemplares similares
-
Efavirenz Promotes β-Secretase Expression and Increased Aβ(1-40,42) via Oxidative Stress and Reduced Microglial Phagocytosis: Implications for HIV Associated Neurocognitive Disorders (HAND)
por: Brown, Lecia A. M., et al.
Publicado: (2014) -
Stimulation of cannabinoid receptor 2 (CB(2)) suppresses microglial activation
por: Ehrhart, Jared, et al.
Publicado: (2005) -
Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
por: Zhang, She-Qing, et al.
Publicado: (2013) -
Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD)
por: Salemi, Jon, et al.
Publicado: (2011) -
Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression
por: Rezai-Zadeh, Kavon, et al.
Publicado: (2008)